14 Aug 2025
43min 14sec
Join us for the Market Access Summit panel discussion on the evolving role of private payers in Canada’s healthcare system. This session features insights from industry leaders Bobby Currie (Manulife), Martin Chung (Equitable Life Canada), and David Greiss (Green Shield Canada). Discover how: Private insurers are adapting to healthcare system pressures The challenges of providing […]
14 Aug 2025
37min 38sec
Join leading experts Dr. Quinn Grundy (University of Toronto), Andrea Jaray (Alexion Canada), and Sandra Hanna (Neighborhood Pharmacy Association of Canada) as they dive deep into the evolution, challenges, and future of Patient Support Programs (PSPs) in Canada. The panel explores: How PSPs fill critical healthcare system gaps Learn how to support patients with complex […]
04 Aug 2025
42min 42sec
Join leading experts from Bayer, Health Canada, Arthritis Society, and Knight Therapeutics as they dive deep into the challenges of bringing innovative treatments to Canadian patients. Key highlights include: insights from regulatory, industry, and patient perspectives, challenges in Canada’s drug approval process, innovative approaches to streamline market access and more. In this panel discussion, industry […]
18 Jun 2025
32min 29sec
Join leading experts from Roche, University of Toronto, and industry as they dive deep into the future of real-world evidence (RWE). Discover how Canada can become a global leader in pharmaceutical data, learn about critical challenges in RWE implementation, and explore strategies for more effective market access and healthcare innovation. Key insights include: – Global […]
18 Jun 2025
44min 59sec
Dive into the world of biosimilars with leading Canadian healthcare experts! This panel discussion explores the evolution of biosimilar adoption, patient access challenges, healthcare stakeholder perspectives, and the future of innovative medical treatments. Learn about cost savings, patient support programs, and how Canada is becoming a global leader in biosimilar implementation. Featuring insights from top […]
04 Aug 2025
25min 15sec
Industry experts from Insight Biosciences, AbbVie, GSK, and IQVIA discuss the latest PMPRB guidelines and their potential impact on drug pricing, market access, and healthcare innovation in Canada. Key Topics: – PMPRB’s evolving regulatory approach – Potential effects on drug launches and R&D investments – Strategies for pharmaceutical manufacturers – Balancing drug pricing and patient […]
17 Jun 2025
47min 49sec
Join leading experts from Christine Donaldson of Health Pro Canada, Kristin Willemsen of Canadian Generic Pharmaceutical Association, Shanzeh Choudhry of University of Toronto, and Dr. Alexandra Wright of SCANH Health as they discuss critical strategies to manage and mitigate drug supply challenges. Learn about collaborative approaches, risk assessment frameworks, and proactive solutions to ensure medication […]
09 Jun 2025
29min 36sec
Discover how the National Institute for Health and Care Excellence (NICE) is revolutionizing healthcare technology assessment. In this exclusive presentation, Kendall from NICE reveals key strategies for faster, more efficient medical evaluations, international collaboration, and improving patient access to innovative treatments. Learn about NICE’s approach to horizon scanning, methods development, and supporting the NHS in […]
05 Jun 2025
38min 21sec
Dive deep into the Patented Medicines Prices Review Board’s new guidelines with Guillaume Couillard, of PMPRB. Learn about key changes in price monitoring, stakeholder engagement, and how these updates will impact pharmaceutical companies in Canada. Discover the PMPRB’s evolving mandate, scientific review process, and what to expect in 2025. Essential viewing for pharma executives, policy […]
Loading...
